User's Publication |
19553
Fujino H, Sonoda-Fukuda E, Isoda L, Kawabe A, Takarada T, Kasahara N, Kubo S.
Retroviral Replicating Vectors Mediated Prodrug Activator Gene Therapy in a Gastric Cancer Model
Int J Mol Sci
2023
24(19):14823
PubMed ID: 37834271
DOI: 10.3390/ijms241914823
|
19679
Zhang J, Fu L, Yasuda-Yoshihara N, Yonemura A, Wei F, Bu L, Hu X, Akiyama T, Kitamura F, Yasuda T, Semba T, Uchihara T, Itoyama R, Yamashita K, Eto K, Iwagami S, Yashiro M, Komohara Y, Baba H, Ishimoto T.
IL-1β derived from mixed-polarized macrophages activates fibroblasts and synergistically forms a cancer-promoting microenvironment
Gastric Cancer
2023
26(2):187-202
PubMed ID: 36513910
DOI: 10.1007/s10120-022-01352-3
|
19955
Morinaga T, Iwatsuki M, Yamashita K, Yasuda-Yoshihara N, Yamane T, Matsumoto C, Harada K, Eto K, Kurashige J, Ishimoto T, Baba Y, Miyamoto Y, Yoshida N, Baba H.
Dynamic Alteration in HLA-E Expression and Soluble HLA-E via Interaction with Natural Killer Cells in Gastric Cancer
Ann Surg Oncol
2023
30(2):1240-1252
PubMed ID: 36149610
DOI: 10.1245/s10434-022-12505-0
|
21459
Hori N, Tazawa H, Li Y, Okura T, Kikuchi S, Kuroda S, Ohara T, Noma K, Nishizaki M, Urata Y, Kagawa S, Fujiwara T.
Intraperitoneal Administration of p53-armed Oncolytic Adenovirus Inhibits Peritoneal Metastasis of Diffuse-type Gastric Cancer Cells.
Anticancer Res
2023
43(11):4809-4821
PubMed ID: 37909979
DOI: 10.21873/anticanres.16678
|
21486
Lou M, Iwatsuki M, Wu X, Zhang W, Matsumoto C, Baba H.
Cancer-Associated Fibroblast-Derived IL-8 Upregulates PD-L1 Expression in Gastric Cancer Through the NF-κB Pathway.
Ann Surg Oncol
2023
PubMed ID: 38006530
DOI: 10.1245/s10434-023-14586-x
|
17567
Takashima Y, Komatsu S, Ohashi T, Kiuchi J, Kamiya H, Shimizu H, Arita T, Konishi H, Shiozaki A, Kubota T, Okamoto K, Fujiwara H, Tsuda H, Otsuji E.
Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer
Cancer Sci
2022
113(6):1984-1998
PubMed ID: 35307915
DOI: 10.1111/cas.15342
|
20571
Fu L, Yonemura A, Yasuda-Yoshihara N, Umemoto T, Zhang J, Yasuda T, Uchihara T, Akiyama T, Kitamura F, Yamashita K, Okamoto Y, Bu L, Wei F, Hu X, Liu Y, Ajani JA, Tan P, Baba H, Ishimoto T.
Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer.
Gastric Cancer
2022
PubMed ID: 35166958
DOI: 10.1007/s10120-022-01283-z
|
20600
Xie J, Fu L, Zhang J.
Analysis of Influencing Factors on the Occurrence and Development of Gastric Cancer in High-Incidence Areas of Digestive Tract Tumors Based on High Methylation of GPX3 Gene.
J Oncol
2022
3094881
PubMed ID: 35069731
DOI: 10.1155/2022/3094881
|
20627
Soda T, Gen Y, Terasaki K, Iwai N, Kitaichi T, Dohi O, Taketani H, Seko Y, Umemura A, Nishikawa T, Yamaguchi K, Moriguchi M, Konishi H, Naito Y, Itoh Y, Yasui K.
Loss of KAP3 decreases intercellular adhesion and impairs intracellular transport of laminin in signet ring cell carcinoma of the stomach.
Sci Rep
2022
12(1):5050
PubMed ID: 35322078
DOI: 10.1038/s41598-022-08904-8
|
20887
Wang Y, Chen H, Liu W, Yan H, Zhang Y, Cheung AHK, Zhang J, Chen B, Liang L, Zhou Z, Wong CC, Wu WKK, Chan MWY, Cheng ASL, Ma BBY, Yu J, Lo KW, To KF, Kang W.
MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target.
Theranostics
2022
12(15):6509-6526
PubMed ID: 36185598
DOI: 10.7150/thno.75431
|
18099
Kato T, Nakamori M, Matsumura S, Nakamura M, Ojima T, Fukuhara H, Ino Y, Todo T, Yamaue H.
Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
Oncol Lett
2021
21(6):490
PubMed ID: 33968206
DOI: 10.3892/ol.2021.12751
|
13323
Nishibeppu K, Komatsu S, Kiuchi J, Kishimoto T, Takashima Y, Shoda K, Arita T, Kosuga T, Konishi H, Shiozaki A, Kubota T, Okamoto K, Fujiwara H, Tsuda H, Otsuji E.
TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer.
J Cancer
2021
PubMed ID: 33391428
DOI: 10.7150/jca.47577
|
13337
Kim S, Ahn JM, Bae WJ, Han JH, Lee D.
Quantitation of ligand is critical for ligand-dependent MET signalling activation and determines MET-targeted therapeutic response in gastric cancer.
Gastric Cancer
2021
24(3):577-588
PubMed ID: 33164142
DOI: 10.1007/s10120-020-01139-4
|
20002
Yasufuku I, Saigo C, Kito Y, Yoshida K, Takeuchi T.
Prognostic significance of LDL receptor-related protein 1B in patients with gastric cancer.
J Mol Histol
2021
PubMed ID: 33389427
DOI: 10.1007/s10735-020-09932-2
|
20005
Iwata Y, Yasufuku I, Saigo C, Kito Y, Takeuchi T, Yoshida K.
Anti-fibrotic properties of an adiponectin paralog protein, C1q/TNF-related protein 6 (CTRP6), in diffuse gastric adenocarcinoma.
J Cancer
2021
12(4):1161-1168
PubMed ID: 33442414
DOI: 10.7150/jca.46765
|
20098
Tsuji T, Maeda Y, Kita K, Murakami K, Saya H, Takemura H, Inaki N, Oshima M, Oshima H.
FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells.
Oncogene
2021
PubMed ID: 33795838
DOI: 10.1038/s41388-021-01757-x
|
20148
Kubo H, Murayama Y, Ogawa S, Matsumoto T, Yubakami M, Ohashi T, Kubota T, Okamoto K, Kamiya M, Urano Y, Otsuji E.
β-Galactosidase is a target enzyme for detecting peritoneal metastasis of gastric cancer.
Sci Rep
2021
11(1):10664
PubMed ID: 34021168
DOI: 10.1038/s41598-021-88982-2
|
20415
Ikari N, Serizawa A, Tanji E, Yamamoto M, Furukawa T.
Analysis of RHOA mutations and their significance in the proliferation and transcriptome of digestive tract cancer cells.
Oncol Lett
2021
22(4):735
PubMed ID: 34466148
DOI: 10.3892/ol.2021.12996
|
16803
Egawa N, Tanaka T, Matsufuji S, Yamada K, Ito K, Kitagawa H, Okuyama K, Kitajima Y, Noshiro H.
Antitumor effects of low-dose tipifarnib on the mTOR signaling pathway and reactive oxygen species production in HIF-1α-expressing gastric cancer cells
FEBS Open Bio
2021
11(5):1465-1475
PubMed ID: 33773069
DOI: 10.1002/2211-5463.13154
|
16974
Khwanchanok Mokmued, Bhanuz Dechayont, Pathompong Phuaklee, Chantubpapa Liplung, Harit Muangpoolsawad, Nitra Nuengchamnong, Nuntika Prommee
Evaluation of anti-inflammatory, cytotoxic, anti-H. pylori, antioxidant activities, and phytochemical compositions of Shirakiopsis indica (Willd.) Esser
ScienceAsia
2021
47:549
DOI: 10.2306/scienceasia1513-1874.2021.068
|
12030
Yoshizawa N, Sugimoto K, Tameda M, Inagaki Y, Ikejiri M, Inoue H, Usui M, Ito M, Takei Y.
miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma.
Oncol Lett
2020
PubMed ID: 32218818
DOI: 10.3892/ol.2020.11357
|
12160
Naranpraphai Suthisamphat, Bhanuz Dechayont , Pathompong Phuaklee , Onmanee Prajuabjinda, Ratha-Korn Vilaichone, Arunporn Itharat, Khwanchanok Mokmued, and Nuntika Prommee
Anti- Helicobacter pylori, Anti-Inflammatory, Cytotoxic, and Antioxidant Activities of Mace Extracts from Myristica fragrans
Evidence-Based Complementary and Alternative Medicine
2020
PubMed ID: 32308716
DOI: 10.1155/2020/7576818
|
13600
Sano H, Futamura M, Gaowa S, Kamino H, Nakamura Y, Yamaguchi K, Tanaka Y, Yasufuku I, Nakakami A, Arakawa H, Yoshida K.
p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers
Biochem Biophys Res Commun
2020
529(3):582-589.
PubMed ID: 32736677
DOI: 10.1016/j.bbrc.2020.05.168
|
14832
Saito S, Kitamura-Muramatsu Y, Komine F, Polat M, Takeshima SN, Takei M, Aida Y.
Absence of bovine leukemia virus proviral DNA in Japanese human blood cell lines and human cancer cell lines
Arch Virol
2020
165(1):207-214
PubMed ID: 31776677
DOI: 10.1007/s00705-019-04474-9
|
14847
Uchihara T, Miyake K, Yonemura A, Komohara Y, Itoyama R, Koiwa M, Yasuda T, Arima K, Harada K, Eto K, Hayashi H, Iwatsuki M, Iwagami S, Baba Y, Yoshida N, Yashiro M, Masuda M, Ajani JA, Tan P, Baba H, Ishimoto T.
Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance
Cancer Res
2020
80(16):3222-3235
PubMed ID: 32605995
DOI: 10.1158/0008-5472.CAN-19-3803
|
11202
Shiozaki A, Ariyoshi Y, Iitaka D, Kosuga T, Shimizu H, Kudou M, Konishi T, Shoda K, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Marunaka Y, Ichikawa D, Otsuji E.
Functional analysis and clinical significance of sodium iodide symporter expression in gastric cancer.
Gastric Cancer
2019
PubMed ID: 30191346
DOI: 10.1007/s10120-018-0874-2
|
11409
Echizen K, Horiuchi K, Aoki Y, Yamada Y, Minamoto T, Oshima H, Oshima M.
NF-κB-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells.
Oncogene
2019
PubMed ID: 30700829
DOI: 10.1038/s41388-019-0702-0
|
11733
Shiozaki A, Yamazato Y, Kosuga T, Kudou M, Shoda K, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Marunaka Y, Otsuji E.
Effect of low temperature on the regulation of cell volume after hypotonic shock in gastric cancer cells.
Int. J. Oncol.
2019
PubMed ID: 31432150
DOI: 10.3892/ijo.2019.4853
|
10444
Yuta Sugiyama, Erika Takahashi, Kiwamu Takahashi, Motowo Nakajima, Tohru Tanaka, Shun-ichiro Ogura
Inverse correlation between heme synthesis and the Warburg effect in cancer cells
bioRxiv
2019
August 30
DOI: 10.1101/753079
|
10787
Shimada S, Akiyama Y, Mogushi K, Ishigami-Yuasa M, Kagechika H, Nagasaki H, Fukamachi H, Yuasa Y, Tanaka S.
Identification of selective inhibitors for diffuse-type gastric cancer cells by screening of annotated compounds in preclinical models.
Br. J. Cancer
2018
118:972-984
PubMed ID: 29527007
DOI: 10.1038/s41416-018-0008-y
|
10796
Matsuoka K, Nakagawa F, Kobunai T, Takechi T.
Trifluridine/tipiracil overcomes the resistance of human gastric 5-fluorouracil-refractory cells with high thymidylate synthase expression.
Oncotarget
2018
9:13438-13450
PubMed ID: 29568368
DOI: 10.18632/oncotarget.24412
|
11231
Wang Z, Qu H, Gong W, Liu A.
Up-regulation and tumor-promoting role of SPHK1 were attenuated by miR-330-3p in gastric cancer.
IUBMB Life
2018
PubMed ID: 30281914
DOI: 10.1002/iub.1934
|
4049
Taichi Yoshida, Takashi Maruyama, Masatomo Miura, Masahiro Inoue, Koji Fukuda, Kazuhiro Shimazu, Daiki Taguchi, Hiroaki Kanda, Masanobu Oshima, Yoshiharu Iwabuchi, Hiroyuki Shibata
Dietary intake of pyrolyzed deketene curcumin inhibits gastric carcinogenesis
Journal of Functional Foods
2018
50:192-200
DOI: 10.1016/j.jff.2018.09.033
|
11246
Kimura R, Yoneshige A, Hagiyama M, Otani T, Inoue T, Shiraishi N, Yanagihara K, Wakayama T, Ito A.
Expression of cell adhesion molecule 1 in gastric neck and base glandular cells: Possible involvement in peritoneal dissemination of signet ring cells.
Life Sci.
2018
PubMed ID: 30312702
DOI: 10.1016/j.lfs.2018.10.017
|
11282
Sekino N, Kano M, Matsumoto Y, Sakata H, Murakami K, Toyozumi T, Otsuka R, Yokoyama M, Shiraishi T, Okada K, Kamata T, Ryuzaki T, Matsubara H.
The Antitumor Effects of Metformin on Gastric Cancer In Vitro and on Peritoneal Metastasis.
Anticancer Res.
2018
PubMed ID: 30396946
DOI: 10.21873/anticanres.12982
|
4425
Curcumin inhibition of the effects of Tip α induced cytokine expression in gastric cancer patients
PharmaNutrition
2018
6,100-106
DOI: 10.1016/j.phanu.2018.05.003
|
4190
Kurata A, Yamada M, Ohno SI, Inoue S, Hashimoto H, Fujita K, Takanashi M, Kuroda M.
Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma.
Oncol. Rep.
2018
PubMed ID: 29138864
DOI: 10.3892/or.2017.6093
|
4304
Zhang N, Xu J, Wang Y, Heng X, Yang L, Xing X.
Loss of opioid binding protein/cell adhesion molecule-like gene expression in gastric cancer.
Oncol Lett
2018
PubMed ID: 29805691
DOI: 10.3892/ol.2018.8562
|
13126
Gaowa S, Futamura M, Tsuneki M, Kamino H, Tajima JY, Mori R, Arakawa H, Yoshida K.
Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer.
Cancer Sci
2018
PubMed ID: 30290054
DOI: 10.1111/cas.13824
|
14733
Imamura T, Komatsu S, Ichikawa D, Miyamae M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.
Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma
Carcinogenesis
2018
39(2):263-271
PubMed ID: 29228320
DOI: 10.1093/carcin/bgx139
|
10228
Yamauchi A, Yamamura M, Katase N, Itadani M, Okada N, Kobiki K, Nakamura M, Yamaguchi Y, Kuribayashi F.
Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device.
BMC Cancer
2017
17:234
PubMed ID: 28359316
DOI: 10.1186/s12885-017-3218-4
|
10258
Gen Y, Yasui K, Kitaichi T, Iwai N, Terasaki K, Dohi O, Hashimoto H, Fukui H, Inada Y, Fukui A, Jo M, Moriguchi M, Nishikawa T, Umemura A, Yamaguchi K, Konishi H, Naito Y, Itoh Y.
ASPP2 suppresses invasion and TGF-β1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer.
Cancer Lett.
2017
398:52-61
PubMed ID: 28400336
DOI: 10.1016/j.canlet.2017.04.002
|
10437
Yanoma T, Ogata K, Yokobori T, Ide M, Mochiki E, Toyomasu Y, Yanai M, Kogure N, Kimura A, Suzuki M, Nakazawa N, Bai T, Oyama T, Asao T, Shirabe K, Kuwano H.
Heat shock-induced HIKESHI protects cell viability via nuclear translocation of heat shock protein 70.
Oncol. Rep.
2017
38:1500-1506
PubMed ID: 28731175
DOI: 10.3892/or.2017.5844
|
10552
Okubo S, Uto T, Goto A, Tanaka H, Nishioku T, Yamada K, Shoyama Y.
Berberine Induces Apoptotic Cell Death via Activation of Caspase-3 and -8 in HL-60 Human Leukemia Cells: Nuclear Localization and Structure-Activity Relationships.
Am. J. Chin. Med.
2017
45:1497-1511
PubMed ID: 29025293
DOI: 10.1142/S0192415X17500811
|
10586
Ishii S, Yamashita K, Harada H, Ushiku H, Tanaka T, Nishizawa N, Yokoi K, Washio M, Ema A, Mieno H, Moriya H, Hosoda K, Waraya M, Katoh H, Watanabe M.
The H19-PEG10/IGF2BP3 axis promotes gastric cancer progression in patients with high lymph node ratios.
Oncotarget
2017
8:74567-74581
PubMed ID: 29088808
DOI: 10.18632/oncotarget.20209
|
10686
Imamura T, Komatsu S, Ichikawa D, Miyamae M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Okamoto K, Fujiwara H, Otsuji E.
Low plasma levels of miR-101 are associated with tumor progression in gastric cancer.
Oncotarget
2017
8:106538-106550
PubMed ID: 29290969
DOI: 10.18632/oncotarget.20860
|
5804
Authors: Takashi Okuda Tomohiko Taki Kazuhiro Nishida Yoshiaki Chinen Hisao Nagoshi Chouhei Sakakura Masafumi Taniwaki
Molecular heterogeneity in the novel fusion gene APIP-FGFR2: Diversity of genomic breakpoints in gastric cancer with high-level amplifications at 11p13 and 10q26
Oncology Letters
2017
13(1):215-221
PubMed ID: 28123544
DOI: 10.3892/ol.2016.5386
|
5806
Shiroki T et al
Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.
Cancer Sci
2017
108(5):931-940
PubMed ID: 28235245
DOI: 10.1111/cas.13211
|
9931
Man Hagiyama, Norikazu Yabuta, Daisuke Okuzaki, Takao Inoue, Yasutoshi Takashima, Ryuichiro Kimura, Aritoshi Ri, Akihiko Ito
Modest Static Pressure Suppresses Columnar Epithelial Cell Growth in Association With Cell Shape and Cytoskeletal Modifications
Front Physiol
2017
8:997
PubMed ID: 29259558
DOI: 10.3389/fphys.2017.00997
|
14585
Kikuchi M, Katoh H, Waraya M, Tanaka Y, Ishii S, Tanaka T, Nishizawa N, Yokoi K, Minatani N, Ema A, Kosaka Y, Tanino H, Yamashita K, Watanabe M.
Epigenetic silencing of HOPX contributes to cancer aggressiveness in breast cancer
Cancer Lett
2017
384:70-78
PubMed ID: 27756570
DOI: 10.1016/j.canlet.2016.10.017
|
14619
Kosuga T, Shiozaki A, Kudou M, Yamazato Y, Ichikawa D, Komatsu S, Konishi H, Okamoto K, Shoda K, Arita T, Morimura R, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Fujiwara H, Marunaka Y, Otsuji E.
Blockade of potassium ion transports enhances hypotonicity-induced cytocidal effects in gastric cancer
Oncotarget
2017
8(60):101394-101405
PubMed ID: 29254173
DOI: 10.18632/oncotarget.20736
|
14737
Baba K, Kitajima Y, Miyake S, Nakamura J, Wakiyama K, Sato H, Okuyama K, Kitagawa H, Tanaka T, Hiraki M, Yanagihara K, Noshiro H.
Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines
Sci Rep
2017
7(1):11127
PubMed ID: 28894280
DOI: 10.1038/s41598-017-11769-x
|
5815
Tamura F et al
RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells.
Gastric Cancer
2016
19(1):85-97
PubMed ID: 25532910
DOI: 10.1007/s10120-014-0454-z
|
6041
Tani R, Hayakawa K, Tanaka S, Shiota K.
Linker histone variant H1T targets rDNA repeats.
Epigenetics
2016
11(4):288-302
PubMed ID: 27018843
DOI: 10.1080/15592294.2016.1159369
|
12639
Yamashita K, Kuno A, Matsuda A, Ikehata Y, Katada N, Hirabayashi J, Narimatsu H, Watanabe M.
Lectin microarray technology identifies specific lectins related to lymph node metastasis of advanced gastric cancer
Gastric Cancer
2016
19(2):531-54
PubMed ID: 25840959
DOI: 10.1007/s10120-015-0491-2
|
12874
Altan B, Yokobori T, Ide M, Mochiki E, Toyomasu Y, Kogure N, Kimura A, Hara K, Bai T, Bao P, Suzuki M, Ogata K, Asao T, Nishiyama M, Oyama T, Kuwano H.
Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients
Gastric Cancer
2016
19(3):789-97.
PubMed ID: 26472729
DOI: 10.1007/s10120-015-0551-7
|
12913
Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Ogino S, Fujita Y, Hiramoto H, Hamada J, Shoda K, Kosuga T, Fujiwara H, Okamoto K, Otsuji E.
Tumor exosome-mediated promotion of adhesion to mesothelial cells in gastric cancer cells
Oncotarget
2016
7(35):56855-56863
PubMed ID: 27487135
DOI: 10.18632/oncotarget.10869
|
12951
Kubo H, Kitajima Y, Kai K, Nakamura J, Miyake S, Yanagihara K, Morito K, Tanaka T, Shida M, Noshiro H.
Regulation and clinical significance of the hypoxia-induced expression of ANGPTL4 in gastric cancer
Oncol Lett
2016
11(2):1026-1034.
PubMed ID: 26893686
DOI: 10.3892/ol.2015.4011
|
7097
Otsuka S, Matsumoto K, Nakajima M, Tanaka T, Ogura S.
Oxygen Availability for Porphyrin Biosynthesis Enzymes Determines the Production of Protoporphyrin IX (PpIX) during Hypoxia.
PLoS ONE
2015
10:e0146026
PubMed ID: 26717566
DOI: 10.1371/journal.pone.0146026
|
7334
Ito H, Hasegawa K, Hasegawa Y, Nishimaki T, Hosomichi K, Kimura S, Ohba M, Yao H, Onimaru M, Inoue I, Inoue H.
Silver Nanoscale Hexagonal Column Chips for Detecting Cell-free DNA and Circulating Nucleosomes in Cancer Patients.
Sci Rep
2015
5:10455
PubMed ID: 25994878
DOI: 10.1038/srep10455
|
5819
Yoshida K, Tsujimoto H, Matsumura K, Kinoshita M, Takahata R, Matsumoto Y, Hiraki S, Ono S, Seki S, Yamamoto J, Hase K.
CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer.
Cancer Med
2015
4(9):1322-33
PubMed ID: 26077800
DOI: 10.1002/cam4.478
|
14977
Suenaga M, Yamada S, Fuchs BC, Fujii T, Kanda M, Tanaka C, Kobayashi D, Fujiwara M, Tanabe KK, Kodera Y.
CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence
J Surg Oncol
2015
112(6):622-8
PubMed ID: 26416034
DOI: 10.1002/jso.24056
|
15000
Sakamoto A, Akiyama Y, Shimada S, Zhu WG, Yuasa Y, Tanaka S.
DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer Cells
PLoS One
2015
10(12):e0145630
PubMed ID: 26695186
DOI: 10.1371/journal.pone.0145630
|
15037
Toiyama Y, Tanaka K, Kitajima T, Shimura T, Imaoka H, Mori K, Okigami M, Yasuda H, Okugawa Y, Saigusa S, Ohi M, Inoue Y, Mohri Y, Goel A, Kusunoki M.
Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients
Carcinogenesis
2015
36(12):1474-83
PubMed ID: 26420253
DOI: 10.1093/carcin/bgv139
|
15159
Honda S, Loher P, Shigematsu M, Palazzo JP, Suzuki R, Imoto I, Rigoutsos I, Kirino Y.
Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers
Proc Natl Acad Sci U S A
2015
112(29):E3816-25
PubMed ID: 26124144
DOI: 10.1073/pnas.1510077112
|
10870
Waraya M, Yamashita K, Ema A, Katada N, Kikuchi S, Watanabe M.
Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype
PLoS One
2015
10(10):e0139902
PubMed ID: 26447864
DOI: 10.1371/journal.pone.0139902
|
17451
Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Hiramoto H, Hamada J, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Fujiwara H, Okamoto K, Otsuji E.
Increase in peritoneal recurrence induced by intraoperative hemorrhage in gastrectomy
Ann Surg Oncol
2015
22(3):758-64
PubMed ID: 25201501
DOI: 10.1245/s10434-014-4060-4
|
18176
Sehdev V, Katsha A, Arras J, Peng D, Soutto M, Ecsedy J, Zaika A, Belkhiri A, El-Rifai W.
HDM2 regulation by AURKA promotes cell survival in gastric cancer
Clin Cancer Res
2014
20(1):76-86
PubMed ID: 24240108
DOI: 10.1158/1078-0432.CCR-13-1187
|
18932
Kang W, Tong JH, Chan AW, Zhao J, Dong Y, Wang S, Yang W, Sin FM, Ng SS, Yu J, Cheng AS, To KF.
Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma
J Transl Med
2014
12:80
PubMed ID: 24674326
DOI: 10.1186/1479-5876-12-80
|
3916
Okabe S, Okamoto T, Zhao CM, Chen D, Matsui H.
Acetic acid induces cell death: an in vitro study using normal rat gastric mucosal cell line and rat and human gastric cancer and mesothelioma cell lines.
J Gastroenterol Hepatol
2014
29 Suppl 4:65-9
PubMed ID: 25521736
DOI: 10.1111/jgh.12775
|
5830
Hirai S, Endo S, Saito R, Hirose M, Ueno T, Suzuki H, Yamato K, Abei M, Hyodo I.
Antitumor effects of a sirtuin inhibitor, tenovin-6, against gastric cancer cells via death receptor 5 up-regulation.
PLoS One
2014
9(7):e102831
PubMed ID: 25033286
DOI: 10.1371/journal.pone.0102831
|
15817
Endo F, Nishizuka SS, Kume K, Ishida K, Katagiri H, Ishida K, Sato K, Iwaya T, Koeda K, Wakabayashi G.
A compensatory role of NF-κB to p53 in response to 5-FU-based chemotherapy for gastric cancer cell lines
PLoS One
2014
9(2):e90155
PubMed ID: 24587255
DOI: 10.1371/journal.pone.0090155
|
16016
Nakamura A, Nakajima G, Okuyama R, Kuramochi H, Kondoh Y, Kanemura T, Takechi T, Yamamoto M, Hayashi K.
Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase
Gastric Cancer
2014
17(1):188-95
PubMed ID: 23494117
DOI: 10.1007/s10120-013-0249-7
|
19058
Tanaka T, Nakamura J, Kitajima Y, Kai K, Miyake S, Hiraki M, Ide T, Koga Y, Noshiro H.
Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer
Int J Oncol
2013
42(3):894-902
PubMed ID: 23291975
DOI: 10.3892/ijo.2013.1759
|
5845
Konno-Shimizu M1, Yamamichi N, Inada K, Kageyama-Yahara N, Shiogama K, Takahashi Y, Asada-Hirayama I, Yamamichi-Nishina M, Nakayama C, Ono S, Kodashima S, Fujishiro M, Tsutsumi Y, Ichinose M, Koike K.
Cathepsin E is a marker of gastric differentiation and signet-ring cell carcinoma of stomach: a novel suggestion on gastric tumorigenesis.
PLoS One
2013
8(2):e56766
PubMed ID: 23451082
DOI: 10.1371/journal.pone.0056766
|
6075
Murakami H, Nakanishi H, Tanaka H, Ito S, Misawa K, Ito Y, Ikehara Y, Kondo E, Kodera Y.
Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential.
Gastric Cancer
2013
16(1):74-83
PubMed ID: 22450770
DOI: 10.1007/s10120-012-0149-2
|
15081
Awazu Y, Nakamura K, Mizutani A, Kakoi Y, Iwata H, Yamasaki S, Miyamoto N, Imamura S, Miki H, Hori A.
A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities
Mol Cancer Ther
2013
12(6):913-24
PubMed ID: 23548264
DOI: 10.1158/1535-7163.MCT-12-1011
|
15086
Katase N, Lefeuvre M, Tsujigiwa H, Fujii M, Ito S, Tamamura R, Buery RR, Gunduz M, Nagatsuka H.
Knockdown of Dkk-3 decreases cancer cell migration and invasion independently of the Wnt pathways in oral squamous cell carcinoma‑derived cells
Oncol Rep
2013
29(4):1349-55
PubMed ID: 23354949
DOI: 10.3892/or.2013.2251
|
18963
Mao W, Chen J, Peng TL, Yin XF, Chen LZ, Chen MH.
Role of trefoil factor 1 in gastric cancer and relationship between trefoil factor 1 and gastrokine 1
Oncol Rep
2012
28(4):1257-62
PubMed ID: 22842654
DOI: 10.3892/or.2012.1939
|
5026
Waraya M, Yamashita K, Katoh H, Ooki A, Kawamata H, Nishimiya H, Nakamura K, Ema A, Watanabe M.
Cancer specific promoter CpG Islands hypermethylation of HOP homeobox (HOPX) gene and its potential tumor suppressive role in pancreatic carcinogenesis.
BMC Cancer
2012
12:397
PubMed ID: 22958219
DOI: 10.1186/1471-2407-12-397
|
5848
Kataoka Y, Mukohara T, Tomioka H, Funakoshi Y, Kiyota N, Fujiwara Y, Yashiro M, Hirakawa K, Hirai M, Minami H.
Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks.
Invest New Drugs
2012
30(4):1352-60
PubMed ID: 21655918
DOI: 10.1007/s10637-011-9699-0
|
5850
Miyato H, Tsuno NH, Kitayama J.
Semaphorin 3C is involved in the progression of gastric cancer.
Cancer Sci
2012
103(11):1961-6
PubMed ID: 22924992
DOI: 10.1111/cas.12003
|
5852
Tomioka H, Mukohara T, Kataoka Y, Ekyalongo RC, Funakoshi Y, Imai Y, Kiyota N, Fujiwara Y, Minami H.
Inhibition of the mTOR/S6K signal is necessary to enhance fluorouracil-induced apoptosis in gastric cancer cells with HER2 amplification.
Int J Oncol
2012
41(2):551-8
PubMed ID: 22614071
DOI: 10.3892/ijo.2012.1485
|
5855
Yang Y, Toy W, Choong LY, Hou P, Ashktorab H, Smoot DT, Yeoh KG, Lim YP.
Discovery of SLC3A2 cell membrane protein as a potential gastric cancer biomarker: implications in molecular imaging.
J Proteome Res
2012
11(12):5736-47
PubMed ID: 23116296
DOI: 10.1021/pr300555y
|
15742
Peng DF, Hu TL, Schneider BG, Chen Z, Xu ZK, El-Rifai W.
Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas
PLoS One
2012
7(10):e46214
PubMed ID: 23071548
DOI: 10.1371/journal.pone.0046214
|
7876
Hiraki M, Kitajima Y, Koga Y, Tanaka T, Nakamura J, Hashiguchi K, Noshiro H, Miyazaki K.
Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients.
Ann. Surg. Oncol.
2011
18:3013-9
PubMed ID: 21409489
DOI: 10.1245/s10434-011-1636-0
|
7990
Aoki M, Ishigami S, Uenosono Y, Arigami T, Uchikado Y, Kita Y, Kurahara H, Matsumoto M, Ueno S, Natsugoe S.
Expression of BMP-7 in human gastric cancer and its clinical significance.
Br. J. Cancer
2011
104:714-8
PubMed ID: 21224856
DOI: 10.1038/sj.bjc.6606075
|
19029
Kanamori-Katayama M, Kaiho A, Ishizu Y, Okamura-Oho Y, Hino O, Abe M, Kishimoto T, Sekihara H, Nakamura Y, Suzuki H, Forrest AR, Hayashizaki Y.
LRRN4 and UPK3B are markers of primary mesothelial cells
PLoS One
2011
6(10):e25391
PubMed ID: 21984916
DOI: 10.1371/journal.pone.0025391
|
5866
Nakamura J, Kitajima Y, Kai K, Hashiguchi K, Hiraki M, Noshiro H, Miyazaki K.
Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer.
Am J Pathol
2011
178(2):515-24
PubMed ID: 21281785
DOI: 10.1016/j.ajpath.2010.10.010
|
6115
Kakimoto T, Shiraishi R, Iwakiri R, Fujimoto K, Takahashi H, Hamajima H, Mizuta T, Ideguchi H, Toda S, Kitajima Y, Ozaki I, Matsuhashi S.
Expression patterns of the tumor suppressor PDCD4 and correlation with β-catenin expression in gastric cancers.
Oncol Rep
2011
26(6):1385-92
PubMed ID: 21894439
DOI: 10.3892/or.2011.1450
|
16307
Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Waraya M, Kawamata H, Nishimiya H, Nakamura K, Watanabe M.
Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer
BMC Cancer
2011
11:122
PubMed ID: 21466710
DOI: 10.1186/1471-2407-11-122
|
18757
Kawaguchi K, Etoh T, Suzuki K, Mitui MT, Nishizono A, Shiraishi N, Kitano S.
Efficacy of oncolytic reovirus against human gastric cancer with peritoneal metastasis in experimental animal model
Int J Oncol
2010
37(6):1433-8
PubMed ID: 21042711
DOI: 10.3892/ijo_00000795
|
18967
Fujimoto D, Hirono Y, Goi T, Katayama K, Matsukawa S, Yamaguchi A.
The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion
BMC Cancer
2010
10:443
PubMed ID: 20723226
DOI: 10.1186/1471-2407-10-443
|
5868
Tsunemi S, Nakanishi T, Fujita Y, Bouras G, Miyamoto Y, Miyamoto A, Nomura E, Takubo T, Tanigawa N.
Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer.
Oncol Rep
2010
23(4):949-56
PubMed ID: 20204278
DOI: 10.3892/or_00000719
|
18961
Peng TL, Chen J, Mao W, Liu X, Tao Y, Chen LZ, Chen MH.
Potential therapeutic significance of increased expression of aryl hydrocarbon receptor in human gastric cancer
World J Gastroenterol
2009
15(14):1719-29.
PubMed ID: 19360915
DOI: 10.3748/wjg.15.1719
|
5874
Tu SP, Chi AL, Ai W, Takaishi S, Dubeykovskaya Z, Quante M, Fox JG, Wang TC.
p53 inhibition of AP1-dependent TFF2 expression induces apoptosis and inhibits cell migration in gastric cancer cells.
Am J Physiol Gastrointest Liver Physiol
2009
297(2):G385-96
PubMed ID: 19541923
DOI: 10.1152/ajpgi.90620.2008
|
5876
Takaishi S1, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC.
Identification of gastric cancer stem cells using the cell surface marker CD44.
Stem Cells.
2009
27(5):1006-20
PubMed ID: 19415765
DOI: 10.1002/stem.30
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
18311
Mitsuoka K, Miyoshi S, Kato Y, Murakami Y, Utsumi R, Kubo Y, Noda A, Nakamura Y, Nishimura S, Tsuji A.
Cancer detection using a PET tracer, 11C-glycylsarcosine, targeted to H+/peptide transporter
J Nucl Med
2008
49(4):615-22
PubMed ID: 18344442
DOI: 10.2967/jnumed.107.048231
|
18978
Yamauchi K, Choi IJ, Lu H, Ogiwara H, Graham DY, Yamaoka Y.
Regulation of IL-18 in Helicobacter pylori infection
J Immunol
2008
180(2):1207-16
PubMed ID: 18178861
DOI: 10.4049/jimmunol.180.2.1207
|
6139
Jin SH, Akiyama Y, Fukamachi H, Yanagihara K, Akashi T, Yuasa Y.
IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells.
Int J Cancer
2008
122(5):1040-6
PubMed ID: 17957782
DOI: 10.1002/ijc.23181
|
3900
Miyagawa K, Sakakura C, Nakashima S, Yoshikawa T, Fukuda K, Kin S, Nakase Y, Shimomura K, Oue N, Yasui W, Hayasizaki H, Okazaki Y, Yamagishi H, Hagiwara A, Otsuji E.
Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as A novel marker for the detection of peritoneal micrometastasis.
Anticancer Res
2008
28(2B):1169-79
PubMed ID: 18505053
|
3581
Chang 1, Li W, Jia Z, Satou T, Fushiya S, Koike K.
Biologically active triterpenoid saponins from Ardisia japonica.
J Nat Prod
2007
70(2):179-87
PubMed ID: 17243725
DOI: 10.1021/np0604681
|
15600
Cheng YY, Yu J, Wong YP, Man EP, To KF, Jin VX, Li J, Tao Q, Sung JJ, Chan FK, Leung WK.
Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer
Br J Cancer
2007
97(7):895-901
PubMed ID: 17848950
DOI: 10.1038/sj.bjc.6603968
|
3351
Sakakura, Chouhei, Hagiwara, Akeo, Miyagawa, Koji, Nakashima, Susumu, Yoshikawa, Tetsuji, Kin, Shuichi, Nakase, Yuenn, Ito, Kosei, Yamagishi, Hisakazu, Yazumi, Shujiro, Chiba, Tsutomu, Ito, Yoshiaki
Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
Int J Cancer
2005
113:221-8
PubMed ID: 15386419
DOI: 10.1002/ijc.20551
|